Is Universal Health Realty Income Trust (UHT) overvalued or fairly valued?

MarketChacha shows Universal Health Realty Income Trust's valuation in context — a trailing P/E of about 27.0, a price-to-book of about 3.6 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Universal Health Realty Income Trust's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (2.66×) from reported figures — education, not a rating.

What is Universal Health Realty Income Trust's revenue?

Universal Health Realty Income Trust reported revenue of $99.2M for FY2025, with net profit of $17.6M, per official filings.

What is the share price of Universal Health Realty Income Trust (UHT)?

Universal Health Realty Income Trust last traded at $37.78 (+2.9% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

Universal Health Realty Income Trust

UHT · NYSE · Real Estate · United States

Snapshot

TickerUHT

ExchangeNYSE

SectorReal Estate

IndustryREIT - Healthcare Facilities

CountryUnited States

HeadquartersKing of Prussia, United States

Websitewww.uhrit.com

Filings tracked12

About Universal Health Realty Income Trust

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service-related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute care facilities, surgery centers, childcare centers, and medical office buildings. The Trust has seventy-seven investments in twenty-one states. It is based in King of Prussia, Pennsylvania. Universal Health Realty Income Trust was incorporated in 1986 in Maryland.

Who owns it

Insiders8.4%
Institutions63.5%
Public & other28.2%

264 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.10.74%
Vanguard Portfolio Management LLC6.08%
Vanguard Capital Management LLC4.04%
State Street Corporation2.72%
Geode Capital Management, LLC2.70%
Mirae Asset Global ETFs Holdings Ltd.2.54%
Jane Street Group, LLC1.92%
Two Sigma Investments, LP1.65%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion2.66×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend16.1% → 17.8%

Margin has expanded by about 1.6 points — the business is getting more profitable.

Growth qualityrev 2% · PAT 7%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $25.1M

Next fiscal year

Rev $104.7M

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$99.2M

Net margin

17.8%

ROE

11.6%

Revenue CAGR (2y)

+1.9%

Profit CAGR (2y)

+6.9%

EPS (FY2025)

1.27

Net profit (FY2025)

$17.6M

Ask MarketChacha about UHT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$99.2M	$17.6M	1.27	17.8%	11.6%
FY2024	$99.0M	$19.2M	1.39	19.4%	10.7%
FY2023	$95.6M	$15.4M	1.11	16.1%	7.7%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$25.0M	$5.9M	0.43	23.6%
2026Q1	$24.5M	$5.0M	0.36	20.5%
2025Q3	$25.3M	$4.0M	0.29	15.9%
2025Q2	$24.9M	$4.5M	0.32	18.1%
2025Q1	$24.5M	$4.8M	0.34	19.5%
2024Q3	$24.5M	$4.0M	0.29	16.3%
2024Q2	$24.7M	$5.3M	0.38	21.3%
2024Q1	$25.1M	$5.3M	0.38	21.1%
2023Q3	$24.2M	$3.9M	0.28	16.0%
2023Q2	$23.8M	$3.5M	0.25	14.6%
2023Q1	$23.2M	$4.5M	0.32	19.2%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC8/7/2026
8-K — Results of operations, Exhibits
SEC7/27/2026material
8-K — Executive/director change, Shareholder vote results
SEC6/11/2026material
10-Q filing
SEC5/7/2026
8-K — Results of operations, Exhibits
SEC4/27/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC4/24/2026material
10-K filing
SEC2/25/2026
8-K — Results of operations, Exhibits
SEC2/25/2026material

2025

10-Q filing
SEC11/7/2025
8-K — Results of operations, Exhibits
SEC10/27/2025material
10-Q filing
SEC8/8/2025
8-K — Results of operations, Exhibits
SEC7/28/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.